Compounded versions of semaglutide, the active ingredient in approved diabetes ... Scott Brunner, CEO of the Alliance for ...

The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from ...

The Danish drugmaker Novo Nordisk argues that semaglutide, the active ingredient in Ozempic and Wegovy, are too complex for ...

Novo Nordisk’s CEO has alerted healthcare professionals about the growing risks associated with compounded semaglutide, a ...

It also represents an escalation of efforts to crack down on clinics, compounding pharmacies and other manufacturers selling what it alleges are unsafe knockoff versions of semaglutide.

Demand for popular weight loss drugs such as semaglutide (Wegovy) and tirzepatide (Zepbound) has long outpaced supply, forcing many patients with obesity to visit compounding pharmacies to get ...

GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...

With the rising demand for weight-loss medications, compounding pharmacies have been making headlines lately. On October 30, ...

Compounded semaglutide can be an affordable alternative to brand-name weight loss injections like Ozempic and Wegovy. But ...

While plenty of people rave about the weight loss results you can get from drugs like Ozempic, there’s also been a ton of ...

Compounding pharmacies have increasingly been at the centre of safety concerns around the legitimacy and credibility of ...

Novo Nordisk seeks to put a stop to semaglutide compounding, whereas the FDA agrees to allow compounding of tirzepatide, for ...